Upcoming Events
Log In
Pricing
Free Trial

FDG Case: Metformin

HIDE
PrevNext

0:01

This is a 70-year-old male that came

0:05

for a evaluation of the response to therapy

0:09

for diffuse large b-cell lymphoma.

0:12

And here what I want to show you is this

0:15

intense uptake in the colon that, uh, we can see

0:21

it's kind of patchy, but we ultimately see it throughout.

0:24

And this is a common situation that we encounter

0:29

in the breathing room every day.

0:31

This is the classic pattern of bowel uptake related

0:36

to metformin use.

0:39

Metformin is an anti-diabetic drug that

0:45

promotes glucose uptake in the bowel.

0:48

And we see it

0:49

because we normally don't have the patients

0:52

to stop this, uh, medication.

0:55

Some people may recommend

0:57

that they can be discontinued 48 hours prior

1:00

to the FDG pit,

1:02

but the reality is that we normally don't ask the patients

1:06

to do so unless we know that there is a bowel lesion.

1:11

You can imagine that having this intense, uh,

1:15

uptake may limit your ability to detect

1:19

bowel lesions.

1:21

So this is something that we recognize as a pitfall,

1:25

but we also recognize the limitation that it can provide.

1:30

Ultimately, we always have the CT

1:32

and that may help us, uh, identify other indirect signs

1:36

that may indicate

1:38

that there might be something else aside from just the

1:42

expected bowel optic for metformin.

1:44

The differential diagnosis for these would be colitis,

1:48

but uh, normally colitis is more segmental.

1:51

It's not so diffuse.

1:54

It is also common to see not only large bowel,

1:58

but also intense small bowel uptake.

2:02

So both can be seen with the same medication.

Report

Faculty

Elisa Franquet Elia, MD

Assistant Professor of Radiology

UMass Chan Medical School

Tags

Response and assessment

PET/CT FDG

PET

Oncologic Imaging

Nuclear Medicine

General Oncologic Imaging Concepts

Drug related